New #JITC commentary: Patient-reported outcomes in adoptive cell-therapy trials: mind the gap bit.ly/3uFjb77 EleonoraGhisoni Matteo Morotti George Coukos @sacola00 Massimo Di Maio

Check out our latest original research that assesses time trends in the inclusion of health-related quality of life (QoL) among study endpoints and in the reporting of QoL results in study publications.👇 👇 bit.ly/3SOIZJb Massimo Di Maio Francesco Perrone Laura Marandino

A phase I clinical trial with 13 patients reveals that the connectivity of #MyeloidCell networks in the #tumor microenvironment may correlate to success rates for adoptive cell therapy during metastatic #melanoma. George Coukos scim.ag/5K9

💡NEW study by Alizee Grimm Matteo Morotti Denada Dangaj George Coukos et al., in nature 📈high levels of Prostaglandin E2 in tumors undermine the anti-cancer immune response and compromises TIL-ACT ➡️nature.com/articles/s4158… Université de Lausanne CHUV / Centre hospitalier universitaire vaudois Ludwig Cancer TU München